Over the last few years, the pharmaceutical, biotechnology, and healthcare industries have undergone significant changes. Mergers, global competition, new healthcare laws, and the rapid pace of technology advancement and biotechnological discoveries have changed the business landscape forever.
The Life Sciences Industry and GP Strategies – Facing New Challenges Together
As a result, we are now faced with many new challenges. Due to the crucial demand for high-quality products and health services as well as the pressure to rapidly develop and manufacture safe, affordable, and accessible pharmaceuticals, tremendous stress is placed on every aspect of the industry. Because all of these factors can occur in an environment where errors can be enormously expensive, these challenges are immense.
Advanced technology has revolutionized all facets of regulatory documentation. Many new guidelines specifically for Life Sciences, such as PhRMA; Sunshine Laws; 21 CFR Part 11; and ICH 7, 8, and 9, have had companies striving to keep up. In order for companies to maintain their success, they must be able to integrate information technology and information management with all aspects of thebusiness, including research, QA, regulatory compliance, engineering and facilities, manufacturing, operations, and records management. Our staff includes over 2,500 professionals from an exceptionally broad range of expertise. GP Strategies has the flexibility to provide unified, customized, comprehensive solutions to the most complex issues.
World-Class Sales Training
- Multiple Therapeutic/Disease State Areas
- Customer-Focused Selling Skills
- Sales Transformation/Enablement
- Strong Partnerships
- Medical Content Specialists/Medical Writers
- Key Opinion Leaders
- Subject Matter Experts